Skip to content

The influence of HPV integration status on the recurrence of patients with persistent HPV infection after HSIL cervical conization

The influence of HPV integration status on the recurrence of patients with persistent HPV infection after HSIL cervical conization

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086072
Enrollment
Unknown
Registered
2024-06-25
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High grade squamous intraepithelial lesion, HSIL

Interventions

HPV typing and integration detection: Positive HPV integration after HSIL conization:None
HPV typing and integration detection: Negative HPV integration after HSIL conization :None

Sponsors

Shenzhen Maternity and Child Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Patients with initial diagnosis of cervical HSIL and follow-up HPV infection at 6-12 months after conization surgery, as well as those with the same type of infection before surgery; (2) The subjects voluntarily joined this study, signed an informed consent form, had good compliance, and cooperated with follow-up.

Exclusion criteria

Exclusion criteria: (1) Patients with pregnancy; (2) Patients who have been previously diagnosed with cervical HSIL and have undergone standardized surgical treatment; (3) Patients whose first postoperative review of HPV is more than 12 months after surgery; (4) History of malignant tumors in the reproductive system; (5) Patients with severe immune system diseases and active disease; (6) Patients who are unwilling to undergo follow-up 12 months or 24 months after surgery; (7) Refusal to sign informed consent form.

Design outcomes

Primary

MeasureTime frame
The cumulative risk of HSIL recurrence at 12 months after surgery in the integrated positive group compared to the integrated negative group;

Secondary

MeasureTime frame
The cumulative risk of HSIL recurrence at 24 months after surgery in the integrated positive group compared to the integrated negative group;the general data ;human papilloma virus (HPV) test;Thinprep cytologic test;Vaginoscopy results;

Countries

China

Contacts

Public ContactPing Jin

Shenzhen Maternity and Child Healthcare Hospital

pingjin66@126.com+86 139 2520 6896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026